title: Decreased snake venom metalloproteinase effects via inhibition of enzyme and modification of fibrinogen.
abstract: Since the introduction of antivenom administration 120 years ago to treat venomous snake bit, it has been the gold standard for saving life and limb. However, this therapeutic approach is not always effective and not without potential life-threatening side effects. We tested a new paradigm to abrogate the plasmatic anticoagulant effects of fibrinogenolytic snake venom metalloproteinases by modification of fibrinogen with iron and carbon monoxide and by inhibiting these Zn(2+) dependent metalloproteinases directly with carbon monoxide exposure. Assessment of the fibrinogenolytic effects of venoms collected from Puff adder, Gaboon viper and Indian cobra snakes on plasmatic coagulation kinetics was performed with thrombelastography. Pretreatment of plasma with iron and carbon monoxide exposure markedly attenuated the effects of all three venoms, and direct pretreatment of each venom with carbon monoxide also significantly decreased the ability to compromise coagulation. These results demonstrated that the introduction of a transition metal (e.g., modulation of the α-chain of fibrinogen with iron), modulation of transition metal in heme (e.g., carbon monoxide modulation of fibrinogen-bound heme iron), and direct inhibition of transition metal containing venom enzymes (e.g., CO binding to Zn(2+) or displacing Zn(2+) from the catalytic site) significantly decreased fibrinogenolytic activity. This biometal modulation strategy to attenuate the anticoagulant effects of snake venom metalloproteinases could potentially diminish hemostatic injury in envenomed patients until antivenom can be administered.
authors: The Department of Anesthesiology, University of Arizona College of Medicine, 1501 North Campbell Avenue, P.O. Box 245114, Tucson, AZ, 85724-5114, USA. vgnielsen333@gmail.com.
authors: Vance G
authors: VG
authors: Nielsen
authors: The Department of Anesthesiology, University of Arizona College of Medicine, 1501 North Campbell Avenue, P.O. Box 245114, Tucson, AZ, 85724-5114, USA.
authors: Marc A
authors: MA
authors: Cerruti
authors: The Department of Anesthesiology, University of Arizona College of Medicine, 1501 North Campbell Avenue, P.O. Box 245114, Tucson, AZ, 85724-5114, USA.
authors: Olivia M
authors: OM
authors: Valencia
authors: The Department of Anesthesiology, University of Arizona College of Medicine, 1501 North Campbell Avenue, P.O. Box 245114, Tucson, AZ, 85724-5114, USA.
authors: Quinlan
authors: Q
authors: Amos
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects; D002248:Carbon Monoxide / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005340:Fibrinogen / Q000737:chemistry* / Q000378:metabolism*; D006801:Humans; D007501:Iron / Q000494:pharmacology*; D045726:Metalloproteases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000073176:Naja naja; D012910:Snake Venoms / Q000201:enzymology*; D017819:Viperidae
chemical_list: D000925:Anticoagulants; D004791:Enzyme Inhibitors; D012910:Snake Venoms; D002248:Carbon Monoxide; D005340:Fibrinogen; D007501:Iron; D045726:Metalloproteases
keywords: Carbon monoxide; Fibrinogen; Iron; Snake venom metalloproteinase; Thrombelastography